Department of Physiotherapy, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
Department of Radiology, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India.
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):3817-3822. doi: 10.31557/APJCP.2021.22.12.3817.
Patients with head and neck cancer (HNC) undergoing concurrent chemoradiotherapy (CCRT) often experience pulmonary symptoms. This study evaluated if a 7-week inspiratory muscle training (IMT) program during CCRT is feasible, adherent, and safe in patients with HNC. This study also evaluated the effect of IMT on diaphragm thickness, mobility, and cardiorespiratory parameters in patients with HNC receiving CCRT.
Ten participants with advanced stage HNC receiving CCRT were recruited for the study. Feasibility, adherence, and safety of the intervention were the primary outcomes. Changes in diaphragm thickness and mobility, maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity, forced expiratory volume in first second and functional capacity using 6-MWT were measured at baseline and post 7 weeks of CCRT. IMT was performed at one session per day for 5 days a week for 7 weeks. Eight sets of two minutes of inspiratory manoeuvres with one minute rest period between them with intensity of 40% MIP were given.
Ten participants were included in this study out of the 13 patients screened, indicating the feasibility to be 76.9%. Participants completed a total of 260 training sessions out of the 350 planned sessions denoting the adherence level as 74%. Diaphragm thickness and MEP remained significantly unchanged while significant decline was seen in diaphragm mobility, MIP,FVC, FEV1 and 6-MWD at the end of 7 weeks. No adverse events were reported following the intervention.
Inspiratory muscle training did not show significant effect on the diaphragm thickness, mobility, and cardiorespiratory parameters; however, it was feasible, adherent, and safe in patients with HNC receiving CCRT.
接受同步放化疗(CCRT)的头颈部癌症(HNC)患者常出现肺部症状。本研究评估了在 HNC 患者的 CCRT 期间进行为期 7 周的吸气肌训练(IMT)方案是否可行、依从和安全。本研究还评估了 IMT 对接受 CCRT 的 HNC 患者的膈厚度、移动性和心肺参数的影响。
招募了 10 名接受 CCRT 的晚期 HNC 患者参加该研究。干预措施的可行性、依从性和安全性是主要结果。在 CCRT 前和 7 周后测量膈厚度和移动性、最大吸气压力、最大呼气压力、用力肺活量、第一秒用力呼气量和 6-MWT 的功能能力的变化。IMT 在 CCRT 期间每天进行一次,每周进行 5 天,每次进行 8 组两分钟的吸气运动,每组之间休息一分钟,强度为 40%最大吸气压力。
在筛选出的 13 名患者中,有 10 名患者纳入了本研究,表明可行性为 76.9%。参与者共完成了计划的 350 次训练中的 260 次,表明依从率为 74%。在 7 周结束时,膈厚度和 MEP 保持不变,而膈移动性、MIP、FVC、FEV1 和 6-MWD 显著下降。干预后未报告不良反应。
吸气肌训练对膈肌厚度、移动性和心肺参数没有显著影响;然而,它在接受 CCRT 的 HNC 患者中是可行、依从和安全的。